Severe aortic stenosis imposes chronic pressure overload on the left ventricle, causing progressive myocyte hypertrophy and interstitial fibrosis. Clinicians are increasingly examining extracellular volume after TAVI to understand myocardial tissue recovery. Transcatheter aortic valve implantation swiftly eliminates valvular afterload, yet interstitial myocardial responses vary significantly among patients. A recent landmark investigation provides essential insights into cardiac tissue changes, demonstrating that non-invasive computed tomography can track cellular regression and fibrous remodeling following interventional valve replacement.

Pathophysiology of Interstitial Fibrosis and Left Ventricular Unloading

Chronic pressure overload in severe aortic stenosis triggers compensatory left ventricular hypertrophy to normalize wall stress. However, persistent mechanical strain eventually leads to diffuse reactive myocardial fibrosis and cardiomyocyte enlargement. In addition, chronic microvascular ischemia within the thickened ventricular myocardium accelerates collagen synthesis across the interstitial space. When interventional cardiologists deploy a transcatheter heart valve, the rapid reduction in transvalvular resistance initiates reverse remodeling. Historically, physicians relied primarily on standard echocardiography to document post-procedural regression of left ventricular mass index. While conventional echocardiography reveals macroscopic chamber dimensions, it cannot differentiate between cardiomyocyte shrinkage and interstitial collagen degradation. Fortunately, advanced cardiac computed tomography with delayed contrast enhancement accurately resolves individual myocardial compartments. Specifically, computed tomography measures both cellular volume and extracellular matrix dimensions in a single clinical examination. By evaluating these tissue components independently, clinicians can track how the myocardium restructures following hemodynamic relief. Furthermore, differentiating cellular regression from extracellular matrix clearance helps cardiologists understand persistent diastolic stiffness, residual functional limitation, and late heart failure admissions. Consequently, comprehensive tissue characterization with computed tomography provides far greater prognostic depth than crude geometric measurements alone.

Assessing Extracellular Volume After TAVI With Cardiac CT

To clarify postoperative tissue changes, researchers at Osaka University Hospital evaluated consecutive patients with severe aortic stenosis undergoing transcatheter intervention. Specifically, the investigators examined fifty-five patients who completed cardiac computed tomography with delayed enhancement both before the procedure and at six months post-intervention. The authors rigorously calculated left ventricular mass index, indexed cellular volume, and indexed extracellular volume. At the six-month evaluation, left ventricular mass index decreased significantly, exhibiting a median relative reduction of 21%. Furthermore, both indexed extracellular volume and indexed cellular volume showed marked decreases across the study cohort. The median relative reduction in indexed extracellular volume reached 15%, whereas indexed cellular volume dropped by 22%. These findings confirm that transcatheter valve replacement induces early, measurable regression of myocardial interstitial tissue. Consequently, unloading the left ventricle not only reduces macroscopic wall thickness but also permits substantial interstitial matrix clearance. Nevertheless, the study highlighted meaningful inter-individual variability in structural recovery patterns. While most patients achieved significant reverse remodeling, a distinct subset displayed ongoing matrix expansion. Therefore, computed tomography serves as a powerful, non-invasive imaging modality for tracking myocardial composition during routine post-interventional follow-up.

The Dynamic Paradox of Extracellular Volume Fraction

An intriguing observation from this clinical investigation involves the mathematical behavior of the extracellular volume fraction. Because the relative reduction in indexed cellular volume outpaced the reduction in indexed extracellular volume, the overall extracellular volume fraction increased at six months. Specifically, hypertrophied cardiomyocytes shrank by 22%, while extracellular matrix volume decreased by only 15%. As a result, the proportion of extracellular space relative to total myocardial volume appeared elevated on follow-up imaging. This phenomenon illustrates why clinicians must interpret proportional extracellular volume fractions with caution during early reverse remodeling. When cardiologists observe a rising extracellular volume fraction shortly after transcatheter aortic valve implantation, they might mistakenly assume that interstitial fibrosis is worsening. In reality, rapid regression of cellular hypertrophy temporarily shifts the mathematical denominator faster than the extracellular matrix can clear. Therefore, evaluating absolute indexed extracellular volume rather than relying exclusively on the percentage fraction is essential for accurate clinical interpretation. In addition, this temporal discordance between myocyte recovery and collagen reabsorption highlights that matrix degradation proceeds at a slower biological pace. Understanding this kinetic discrepancy prevents erroneous clinical conclusions when analyzing post-TAVI cross-sectional imaging studies.

Predictors of Indexed Extracellular Volume Worsening

Although the majority of patients exhibited favorable interstitial recovery, 16.4% of the cohort experienced an increase in indexed extracellular volume at six months. Importantly, multivariable analysis identified worsening aortic regurgitation as the primary factor associated with this adverse trajectory. When transcatheter valve deployment leaves residual paravalvular regurgitation or causes central valve leak, the left ventricle experiences persistent diastolic volume overload. Consequently, incomplete hemodynamic relief prevents myocardial stress normalization, maintaining active fibrogenesis within the extracellular compartment. Moreover, the persistence of abnormal diastolic wall tension hinders microvascular perfusion and perpetuates low-grade tissue inflammation. This ongoing mechanical insult impairs myocyte metabolism and stimulates cardiac fibroblasts to deposit excess extracellular collagen. As a result, patients with post-procedural aortic regurgitation fail to achieve reverse interstitial remodeling. In fact, their fibrous tissue burden expands despite valve implantation. Therefore, achieving optimal acute hemodynamic results during transcatheter procedures remains paramount for myocardial recovery. Interventional operators must recognize that residual regurgitation compromises long-term reverse remodeling, impairing patient functional capacity and clinical survival. Furthermore, prompt identification of paravalvular leakage during valve deployment enables timely post-dilation, thereby preserving downstream ventricular recovery.

Translating Imaging Metrics into Clinical Practice

These findings offer valuable guidance for structural heart teams in India and around the globe. As transcatheter valve therapies expand across diverse risk populations, optimizing procedural precision becomes critical to guarantee complete reverse remodeling. Cardiologists must prioritize meticulous pre-procedural computed tomography evaluation to ensure accurate prosthesis sizing and avoid post-deployment regurgitation. Furthermore, when operators encounter calcified valve morphology or complex annular geometries, they should utilize post-dilation or repositionable systems to minimize residual leaks. In addition, post-procedural follow-up should not rely solely on routine transthoracic echocardiography. Incorporating computed tomography-derived tissue markers helps clinicians detect persistent interstitial fibrosis early. Consequently, identifying delayed reverse remodeling enables timely pharmacological intensification with neurohormonal inhibitors, including mineralocorticoid receptor antagonists and sodium-glucose cotransporter-2 inhibitors. These medications promote extracellular collagen breakdown and support ventricular decongestion. In clinical practice, multidisciplinary heart teams can utilize serialized cross-sectional imaging to monitor high-risk patients who show incomplete functional improvement. Such structured surveillance ensures that subtle hemodynamic deficiencies are corrected before irreversible myocardial damage ensues. Ultimately, integrating structural and tissue biomarkers empowers multidisciplinary heart teams to improve patient longevity and functional recovery after transcatheter intervention.

Why does ECV fraction increase post-TAVI despite regression of myocardial fibrosis?

Although the total indexed extracellular volume decreases after aortic valve intervention, the relative extracellular volume fraction often rises temporarily. This paradoxical finding occurs because hypertrophied cardiomyocytes shrink faster than the collagen matrix dissolves. Consequently, the proportional ratio of extracellular matrix to total myocardium expands transiently. Clinicians must distinguish between percentage fractions and indexed absolute volumes to avoid misinterpreting physiological cellular regression as expanding myocardial fibrosis.

How does residual aortic regurgitation affect myocardial interstitium following TAVI?

Suboptimal hemodynamic relief caused by residual aortic regurgitation introduces persistent volume overload into the left ventricle immediately after valve deployment. Consequently, diastolic wall stress remains elevated, which prevents myocardial microvascular recovery and stimulates persistent interstitial fibrogenesis. Patients exhibiting paravalvular leak or worsening regurgitation fail to achieve normal cellular regression. Therefore, their indexed extracellular volume increases over time, contributing to ongoing diastolic dysfunction, adverse remodeling, and poorer cardiovascular outcomes.

What advantages does cardiac CT offer over CMR for serial ECV assessment in TAVI patients?

Cardiac computed tomography provides rapid, high-spatial-resolution volume quantification that integrates seamlessly into pre-procedural annular sizing and post-implant structural surveillance. Unlike cardiovascular magnetic resonance, cardiac computed tomography avoids metal artifact distortions from metallic bioprosthetic valve stents or cardiac pacemakers. Furthermore, modern spectral and delayed-enhancement computed tomography protocols accurately quantify myocardial extracellular volume and cell volume without requiring dedicated magnet time, making longitudinal imaging highly accessible for post-TAVI follow-up.

Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.

References

1. Matsuhiro Y et al. Extracellular Volume Remodeling After Transcatheter Aortic Valve Implantation: Factors Associated With Indexed Extracellular Volume Worsening. Catheter Cardiovasc Interv. 2026 Sep 17. doi: 10.1002/ccd.70884. PMID: 42752004.
2. Treibel TA, Kozor R, Schofield R, et al. Reverse myocardial remodeling following valve replacement in patients with aortic stenosis. J Am Coll Cardiol. 2018;71(8):860-871.
3. Kavsur R, Dobner S, Hirasawa K, et al. Extracellular volume fraction by computed tomography predicts prognosis after transcatheter aortic valve replacement. Circ J. 2024;88(4):499-506.